STL Volume 29 Number 1

STL Volume 29 Number 1
3 POSTS 0 COMMENTS
Purchase PDF for $2.79
Spesolimab, A Novel Interleukin-36 Inhibitor for Generalized Pustular Psoriasis Flares

Spesolimab, A Novel Interleukin-36 Inhibitor for Generalized Pustular Psoriasis Flares in Adult Patients

Explore the groundbreaking role of Spesolimab, a novel interleukin-36 inhibitor, in treating Generalized Pustular Psoriasis flares in adults. This article presents key findings from phase 1 and 2 clinical trials, emphasizing Spesolimab's effectiveness and safety.
1726 nm Lasers for the Treatment of Acne Vulgaris

1726 nm Lasers for the Treatment of Acne Vulgaris

Explore the efficacy of 1726 nm lasers, specifically AviClear and Accure systems, in treating moderate to severe acne vulgaris, offering a safe and effective alternative to systemic therapies.
Update on Drugs & Devices: January - February 2024

Update on Drugs & Devices: January – February 2024

Update on Roflumilast foam, 0.3% (Zoryve®), Birch triterpenes gel (Filsuvez®), Rapamycin anhydrous gel, 3.9% (Qtorin™), Bimekizumab-bkzx for SC use (Bimzelx®), Secukinumab for SC use (Cosentyx®), and Ustekinumab-auub for SC/IV use (Wezlana™).

POPULAR

Advertisement